We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Medpace
MEDP
$16.5B
| $23.6M | 0.03% |
445,017
+278,000
| +166% | +$15.3M |
|
527
Tractor Supply
TSCO
$18B
| $23.4M | 0.03% |
1,400,255
-469,015
| -25% | -$8.41M |
|
528
Domino's
DPZ
$11.6B
| $23.2M | 0.03% |
93,616
-14,179
| -13% | -$3.73M |
|
529
Conagra Brands
CAG
$7.23B
| $23.1M | 0.03% |
1,079,342
+1,026,514
| +1,943% | +$33.2M |
|
530
Okta
OKTA
$25.8B
| $23M | 0.03% |
361,249
+301,408
| +504% | +$17.9M |
|
531
Royal Caribbean
RCL
$85.6B
| $22.8M | 0.03% |
232,770
+207,422
| +818% | +$22.7M |
|
532
NOV
NOV
$7B
| $22.7M | 0.03% |
884,858
+68,344
| +8% | +$2.36M |
|
533
Parker-Hannifin
PH
$135B
| $22.7M | 0.03% |
152,149
-324
| -0.2% | -$52.4K |
|
534
Thomson Reuters
TRI
$44.1B
| $22.6M | 0.03% |
443,665
+47,039
| +12% | +$2.52M |
|
535
ICICI Bank
IBN
$108B
| $22.1M | 0.03% |
2,143,156
+403,442
| +23% | +$3.81M |
|
536
Open Text
OTEX
$6.04B
| $22.1M | 0.03% |
676,857
+451,095
| +200% | +$15.2M |
|
537
SLB Ltd
SLB
$75B
| $21.8M | 0.03% |
605,253
-277,370
| -31% | -$13.7M |
|
538
Timken Company
TKR
$9.03B
| $21.7M | 0.03% |
581,920
+129,457
| +29% | +$5.24M |
|
539
Arthur J. Gallagher & Co
AJG
$63.6B
| $21.7M | 0.03% |
294,030
-50,447
| -15% | -$3.77M |
|
|
LLL
540
DELISTED
L3 Technologies, Inc.
LLL
| $21.6M | 0.03% |
124,104
-1,373,671
| -92% | -$265M |
|
|
ENIA
541
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $21.5M | 0.03% |
2,414,868
+187,256
| +8% | +$1.54M |
|
542
Sempra
SRE
$54.8B
| $21.2M | 0.02% |
391,262
+206,534
| +112% | +$11.8M |
|
543
Brown-Forman Class B
BF.B
$13.1B
| $21.2M | 0.02% |
444,696
+49,070
| +12% | +$2.33M |
|
544
Palo Alto Networks
PANW
$297B
| $21M | 0.02% |
669,414
-578,100
| -46% | -$18M |
|
545
Designer Brands
DBI
$333M
| $21M | 0.02% |
849,555
-21,549
| -2% | -$578K |
|
546
Deluxe
DLX
$1.15B
| $20.8M | 0.02% |
541,483
-8,474
| -2% | -$404K |
|
547
Dr. Reddy's Laboratories
RDY
$10.2B
| $20.6M | 0.02% |
2,728,670
+66,610
| +3% | +$468K |
|
548
Tandem Diabetes Care
TNDM
$1.56B
| $20.5M | 0.02% |
540,036
+161,526
| +43% | +$5.7M |
|
549
Broadcom
AVGO
$2.04T
| $20.4M | 0.02% |
804,230
-4,331,660
| -84% | -$102M |
|
550
Tenet Healthcare
THC
$21.1B
| $20.4M | 0.02% |
1,191,108
+522,799
| +78% | +$12.7M |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.